ОЦЕНКА ТЕРАПЕВТИЧЕСКОЙ ЭФФЕКТИВНОСТИ ВАРФАРИНА ПРОИЗВОДСТВА ЗАО «КАНОНФАРМА ПРАДАКШЕН» (РОССИЯ)
Warfarin by «Kanonpharma production» (Russia) and original Warfarin have the similar safety and tolerability. We need some increase of dose of Warfarin by «Kanonpharma production» to reach target rate of INR, then in case of original Warfarin usage. But for 1.5 month of treatment this characteristic...
Main Authors: | М. В. Хруслов, Е. В. Ройтман |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2014-02-01
|
Series: | Архивъ внутренней медицины |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/262 |
Similar Items
-
THE INITIAL STAGE OF TESTING THE DEVELOPED APPARATUS TO DETERMINE THE INTERNATIONAL NORMALIZED RATIO
by: Natalya Valeryevna Aksyutina, et al.
Published: (2018-12-01) -
MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS
by: V. I. Petrov, et al.
Published: (2014-08-01) -
Warfarin and its role in the prevention of thromboembolism in atrial fibrillation (lecture)
by: Y. V. Shubik
Published: (2015-12-01) -
Тактика хирургических вмешательств в амбулаторных условиях и ранняя ультразвуковая диагностика осложнений у пациентов с целевыми значениями международного нормализованного отношения
Published: (2015-12-01) -
State of dental care for patients with ischemic circulation by ischemic type
Published: (2020-04-01)